Daniel M. Harrison

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor, Pei‐Ran Ho, Nolan Campbell et al. · The Lancet Neurology · 2018 · 327 citations · Full text

Disease Progression, Neurological Disorder, Immunology +8

Association of Cortical Lesion Burden on 7-T Magnetic Resonance Imaging With Cognition and Disability in Multiple Sclerosis

Daniel M. Harrison, Snehashis Roy, Jiwon Oh et al. · JAMA Neurology · 2015 · 189 citations · Full text

Progressive multifocal leukoencephalopathy in transplant recipients

Farrah J. Mateen, Rajanandini Muralidharan, Marco Carone et al. · Annals of Neurology · 2011 · 179 citations

OH and HO2 radical chemistry in a forested region of north-western Greece

Nicola Carslaw, D. J. Creasey, Daniel M. Harrison et al. · Atmospheric Environment · 2001 · 159 citations

Organic Geochemistry, Environmental Chemistry, Radical Emission +11

COVID-19 mRNA vaccination leading to CNS inflammation: a case series

Mahsa Khayat-Khoei, Shamik Bhattacharyya, Joshua Katz et al. · Journal of Neurology · 2021 · 130 citations · Full text

Vaccination, Vaccine Development, Covid-19 Pandemic +5